Novel Therapeutic Approaches And Targets For Treatment Of Chronic Urticaria: New Insights And Promising Targets For A Challenging Disease.
CONCLUSION: Although omalizumab has been a breakthrough in the treatment of CSU, many patients do not completely benefit and even require more effective treatments. Novel drugs are under investigation with promising results.
PMID: 32603278 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Martina E, Diotallevi F, Bianchelli T, Paolinelli M, Offidani A Tags: Curr Pharm Biotechnol Source Type: research